INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nutex Health, Inc. - NUTX
Igår, 23:50
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nutex Health, Inc. - NUTX
PR Newswire
NEW YORK, March 12, 2026
NEW YORK , March 12, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Nutex Health, Inc. ("Nutex" or the "Company") (NASDAQ: NUTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
The investigation concerns whether Nutex and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On March 5, 2025, Nutex announced its financial and operating results for the fourth quarter and fiscal year 2025, revealing a revenue decrease of $105.9 to $151.7 million for the three months ended December 31, 2025 due in part to a "one-time $55.0 million cumulative true-up of 18,950 arbitration claims that arbitrators determined were ineligible under the IDR process."
On this news, Nutex's stock price fell $15.06 per share, or 14.3%, to close at $90.28 per share on March 6, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud , breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com .
Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Danielle Peyton
Pomerantz LLP
dpeyton@pomlaw.com
646-581-9980 ext. 7980
SOURCE Pomerantz LLP
Ämnen i artikeln
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nutex Health, Inc. - NUTX
Igår, 23:50
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nutex Health, Inc. - NUTX
PR Newswire
NEW YORK, March 12, 2026
NEW YORK , March 12, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Nutex Health, Inc. ("Nutex" or the "Company") (NASDAQ: NUTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
The investigation concerns whether Nutex and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On March 5, 2025, Nutex announced its financial and operating results for the fourth quarter and fiscal year 2025, revealing a revenue decrease of $105.9 to $151.7 million for the three months ended December 31, 2025 due in part to a "one-time $55.0 million cumulative true-up of 18,950 arbitration claims that arbitrators determined were ineligible under the IDR process."
On this news, Nutex's stock price fell $15.06 per share, or 14.3%, to close at $90.28 per share on March 6, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud , breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com .
Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Danielle Peyton
Pomerantz LLP
dpeyton@pomlaw.com
646-581-9980 ext. 7980
SOURCE Pomerantz LLP
Ämnen i artikeln
Analyser
Rusta
Oljepriset
Clas Ohlson
Kritiken mot Kinnevik
Analyser
Rusta
Oljepriset
Clas Ohlson
Kritiken mot Kinnevik
Marknadsöversikt
1 DAG %
Senast
1 mån
